icone plus
Contact Abonnez-vous aux actualités
Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
Insufficient
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia".
Therapeutic use
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
knKS24AsvN7Qb4EN
Listen
